Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Diabetic Ketoacidosis
- Type 1 Diabetes
- Type 2 Diabetes
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: Non-RandomizedIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04567225
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Mohammed Al jaghbeer, MD The Cleveland Clinic